Found 14 matching trials
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) PHASE3 The purpose of this study is to evaluate the efficacy and safety of rocatin...
Show More Location
Cahaba Dermatology and Skin Health Center
Learn More & Join Trial
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis PHASE3 The primary objective of this study is to assess successful self-administra...
Show More Location
Kern Research Inc
Learn More & Join Trial
A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants PHASE1 The primary objective of the study is to evaluate the pharmacokinetics of r...
Show More Location
Huashan Hospital Affiliated to Fudan University?
Learn More & Join Trial
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) PHASE3 The purpose of this study is to evaluate the efficacy and safety of rocatin...
Show More Location
Cahaba Dermatology and Skin Health Center
Learn More & Join Trial
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) PHASE3 The primary objective of this study is to describe the long-term safety and...
Show More Location
Cahaba Dermatology and Skin Health Center
Learn More & Join Trial
A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants PHASE1 The primary objective of the study is to evaluate the pharmacokinetics (PK)...
Show More Location
Fortrea Clinical Research Unit - Daytona Beach
Learn More & Join Trial
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis PHASE3 The main objective of the study will be to evaluate the efficacy of rocatin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) PHASE3 The primary objectives of this study are to:
* estimate vaccine response i...
Show More Location
Affiliated Dermatology
Learn More & Join Trial
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) PHASE3 The co-primary objectives of the study are to:
* Evaluate the efficacy of ...
Show More Location
Research Solutions of Arizona, PC
Learn More & Join Trial
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma PHASE2 The primary objective of this study is to describe the efficacy of rocatinl...
Show More Location
Kern Research Inc
Learn More & Join Trial